Literature DB >> 11305573

A longitudinal insufficiency fracture of the tibia in association with a healed chronic osteomyelitis.

A Feydy1, R Carlier, C Mutschler, L Bernard, V Leriverend, C Vallée.   

Abstract

Longitudinal stress fracture of the tibia often present with an atypical clinical presentation which can be mistaken for osseous tumor or osteomyelitis. We present a case of longitudinal stress fracture of the tibia which occurred in a patient with healed chronic osteomyelitis of the tibia. Magnetic resonance imaging failed to make the correct diagnosis. Accurate diagnosis was only obtained by helical CT which showed the longitudinal fracture line. Magnetic resonance imaging showed only non-specific signs of bone marrow edema, suggesting recurrence of osteomyelitis. Magnetic resonance imaging can be misleading in the absence of direct visualization of the fracture line.

Entities:  

Mesh:

Year:  2000        PMID: 11305573     DOI: 10.1007/s003300000503

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  3 in total

1.  Spontaneous multiple insufficiency fractures after pelvic abscess and sepsis in a rheumatoid arthritis patient treated with high-load corticosteroid therapy: a case report.

Authors:  Takeshi Mochizuki; Shigeki Momohara; Katsunori Ikari; Kouichiro Kawamura; So Tsukahara; Takuji Iwamoto; Shu Kobayashi; Hiroshi Okamoto; Kazumasa Nishimoto; Taisuke Tomatsu
Journal:  Clin Rheumatol       Date:  2007-01-18       Impact factor: 2.980

Review 2.  Looking beyond low bone mineral density: multiple insufficiency fractures in a woman with post-menopausal osteoporosis on alendronate therapy.

Authors:  P Lee; H van der Wall; M J Seibel
Journal:  J Endocrinol Invest       Date:  2007 Jul-Aug       Impact factor: 4.256

3.  Population study evaluating fracture risk among patients with chronic osteomyelitis.

Authors:  Chyi Lo; Fung-Chang Sung; Chih-Hsin Mou; Tzu-Chieh Lin; Chun-Huang Tseng; Ya-Ling Tzeng
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.